ENLV

Enlivex Ltd. ENLV

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 2 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$1.24B

Quarter to Dec 31

Free cash flow

$-10.48M

Quarter to Dec 31

Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ENLV

Loading ratio trend…

About Enlivex Ltd. (ENLV): stock profile, AI score and financials

Enlivex Ltd. (ENLV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ENLV is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 2 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Enlivex Ltd. reports net income of $1.2B, free cash flow of $-10.5M. ENLV trades on the Nasdaq exchange and files with the SEC under CIK 1596812. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ENLV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Enlivex Ltd. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1596812 →